RT Journal Article
SR Electronic
A1 Vinall, Phil
T1 Results of EPITHET
JF MD Conference Express
YR 2008
FD SAGE Publications
VO 8
IS 1
SP 11
OP 12
DO 10.1177/155989770800800106
UL http://mdc.sagepub.com/content/8/1/11.abstract
AB Intravenous recombinant tissue plasminogen activator (tPA) is recommended for the treatment of acute ischemic stroke within the first 3 hours of stroke onset. The objective of the Echoplanar Imaging Thrombolytic Evaluation Trial [EPITHET] was to evaluate the effect of the administration of tPA 3–6 hours after stroke onset as measured by echoplanar magnetic resonance imaging (MRI), diffusion-weighted MRI, and perfusion-weighted MRI.